Stryker Corporation (SYK) Institutional Ownership & Insider Trading

2,253 institutions reported holding Stryker Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 75 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SYKStryker CorporationFollow SYK — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 117.8B
P/E TTM: 31.8
Dividend yield: 1.1%
52-week: —
Next earnings: 29 Oct, in 5 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

2,253 institutions held 80.2% of the shares. Across filers that reported both quarters, shares held changed +1.0%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	2,253	308	+1.0%	774	113	737	144
Mar 26	2,271	299	-0.3%	738	101	708	112
Dec 25	2,272	303	-3.9%	662	83	709	114
Sep 25	2,219	308	+2.9%	654	108	571	69
Jun 25	2,204	303	+0.3%	689	111	591	81
Mar 25	2,162	296	+0.6%	727	103	558	60
Dec 24	2,109	298	-3.8%	621	94	549	62
Sep 24	1,972	293	-0.6%	579	90	547	52

Stryker Corporation — questions

Who owns Stryker Corporation stock?: 2,253 institutions reported Stryker Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (7.2%), VANGUARD CAPITAL MANAGEMENT LLC (5.9%), JPMORGAN CHASE & CO (4.5%).
Are Stryker Corporation insiders buying or selling?: 75 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Stryker Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.